A PHASE II TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF THE COMBINATION OF OBINUTUZUMAB BENDAMUSTINE TREATMENT IN PATIENTS WITH RELAPSED /REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA. (12th June 2019) - García‐Marco, J.; Baltasar Tello, P.; Gonzalez Garcia, E.; Ríos Herranz, E.; Ramírez Payer, Á.; Terol Castera, M.; Champ, D.; Medina Pérez, Á.; Gironella Mesa, M.; Rodríguez Fernández, A.; Muntañola Prat, A.; Suárez Cabrera, A.; et al.